---
schema_version: "secwatch.filing_event.v1"
accession: "0001832511-26-000036"
form_type: "8-K"
ticker: "PIII"
cik: "0001832511"
company_name: "P3 Health Partners Inc."
filed_at: "2026-09-11T20:28:00+00:00"
generated_at: "2026-09-11T20:29:12.086796+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# P3 Health Partners to issue up to $70M in 19.5% preferred units with warrants to CPF

## Summary
- Agreed to issue up to $70M of units to CPF affiliates in tranches; Series D-1 19.5% cumulative preferred stock at $100/share, plus warrants.
- Warrants exercisable for 0.66333% of outstanding Class A and Class V common per $1M funded, exercise price = Nasdaq Minimum Price, 7-year term.
- Preferred stock is senior to common, non-convertible, no voting rights; redemption at $100 plus accrued dividends.
- CPF may designate one independent board member while owning ≥40% of common; standstill limit extended to Dec 31, 2027 at 49.99%.
- Special committee of independent directors approved related-party transaction; securities sold under Reg D to accredited investors.

## SEC filing metadata
- accession: 0001832511-26-000036
- form_type: 8-K
- ticker: PIII
- cik: 0001832511
- company_name: P3 Health Partners Inc.
- filed_at: 2026-09-11T20:28:00+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1832511/000183251126000036/0001832511-26-000036-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1832511/000183251126000036/piii-20260904.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001832511-26-000036
- JSON: https://secwatch.observer/filing/0001832511-26-000036.json
- Plain text: https://secwatch.observer/filing/0001832511-26-000036.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.